Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 105,952,381 | reported | 18 Mar 2019 | tx 1+6,666,667 |
| Urovant Sciences Ltd. | 22,819,798 | reported | 11 Jun 2019 | tx 3+21,338 |
| Arbutus Biopharma Corp | 500,000 | reported | 16 Oct 2017 | tx 1+500,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,189 | 8.58 USD | |
| 10 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 7,500 | 8.35 USD | |
| 07 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 6,649 | 7.97 USD | |
| 18 Mar 2019 | PURCHASE | Axovant Sciences Ltd. | 6,666,667 | 1.50 USD | first after silence |
| 16 Oct 2017 | PURCHASE | Arbutus Biopharma Corp | 500,000 | 100.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 18 Mar 2019.